Clinical Trial Detail

NCT ID NCT03488667
Title Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Kansas Medical Center
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Age Groups: adult senior

No variant requirements are available.